Losing Weight for Less $$$ & You Can’t Pay People to Have Kids
Aug 28, 2024
29:41
auto_awesome Snipd AI
Eli Lilly unveils a new weight-loss drug at half the price, sparking competition in the health market. Mark Zuckerberg reflects on past censorship amid the pandemic and the impact of government pressure on social media. The Kelce brothers land a blockbuster deal for their podcast, signaling a booming market for athletic voices. Meanwhile, declining birth rates worldwide prompt countries to offer incentives for families, but cultural changes complicate the issue. Plus, high-tech cooling systems are trending for outdoor workers amid brutal heat waves.
Read more
AI Summary
Highlights
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Eli Lilly's reduced pricing for its weight-loss drug Zepbound aims to enhance accessibility while combating competition from generics.
Mark Zuckerberg's regret over Facebook's COVID-19 content censorship highlights ongoing debates about free speech and social media's role in crisis communication.
Deep dives
Mark Zuckerberg and Censorship Controversy
Mark Zuckerberg revealed that during the COVID-19 pandemic, the Biden administration pressured Facebook to censor specific posts related to the virus. He reflected on his regret over the decisions made and expressed that they weren't compelled to remove the content but rather chose to do so under external pressure. The White House defended its actions, stating they aimed to encourage responsible communication to prioritize public health. This disclosure has reignited debates surrounding free speech and the role of social media in content moderation, particularly in a time of crisis.
Eli Lilly's Price Cut in Weight Loss Drugs
Eli Lilly has introduced a new version of its GLP-1 weight loss drug, Zepbound, at a significantly reduced price, aiming to increase accessibility for patients. The drug is priced at approximately $399 per month for the lowest dose, a move intended to counteract competition from generic versions entering the market. This pricing strategy allows Eli Lilly to retain market share while adjusting to the ongoing shortage of injectable pens. The new delivery method, requiring a syringe rather than an auto-injector pen, has enabled this price reduction and differentiates it from its competitors.
Rising Podcast Deals and Market Trends
Podcasting has seen a resurgence in mega-deals, highlighted by the Kelsey brothers’ $100 million agreement for their podcast, New Heights. This trend indicates a shift in the podcasting landscape, with publishers seeking to monetize popular shows without exclusive distribution rights. The new model has emerged after several high-profile deals did not yield the expected success, suggesting a more sustainable approach to podcast monetization. This evolution also showcases the growing influence of athletes in media, with successful podcasts becoming a viable career path following their sports careers.
Episode 397: Neal and Toby discuss Eli Lilly’s newest form of Zepbound, their blockbuster weight-loss drug that is half the price of its predecessor. Will this eliminate the competition? Then, Mark Zuckerberg writes a letter expressing his regret for demoting Covid-19 content during the pandemic as it felt ‘pressured’ from the Biden administration. Next, the Kelce brothers just scored a massive $100M deal with Amazon to take their podcast to… new heights. Meanwhile, birth rates around the world are falling and some countries are trying to pay people to start families, and it’s not working. Also, dinner sausages are becoming more and more popular as price-conscious shoppers shift to cheaper meats. Lastly, brutal heat waves sweeping across the country are forcing outdoor workers to wear high-tech cooling systems to survive.